GENTAUR HEADQUARTERS
+32 1641 4407 
+32 1650 9045
Av. de
l' Arme 68 B-1040 Brussels BELGUIM
mail:
[email protected]
Back to promotion Menu
Who We Are
Open Biosystems was founded in 2001 by a team
of researchers who believe deeply in the power of science to improve our
lives, and yours, too. This conviction, coupled with our strong desire to
help our customers succeed, motivates our employees and gives us our
unrelenting focus on developing and delivering the best life sciences tools,
support and services to our customers available in the industry today.
Our business model, based on a collaborative spirit and focused on the
value of product delivery, is inspired by the success of the open source
movement in software. Open source has, over the span of just a few years,
radically empowered small organizations and individuals by giving them the
tools only big companies could previously afford. We aim to speed the
progress of research by letting people use our technology in a manner that’s
substantially more flexible than that of other tools providers.
Open
Biosystems offers products that span Genomics, RNAi and Antibodies.
Building on the rapid sharing model that is at the core of the Human Genome
Project, Open Biosystems collaborates with some of the most innovative life
science investigators working today. We partner with them to bring to
market new products—they have often pioneered the new resources in their own
lab, and we prepare it for widespread use and then provide access to the
research community.
Delivery of genetic content is our most recent
technological breakthrough. Recently, we brought to market the Tranz-vector
system, the safest human-based lentiviral delivery technology. Further
supplementing our already strong line of RNA interference (RNAi) and
complementary DNA (cDNA) products, this technology provides investigators
with superior delivery capabilities for high-quality cellular screening.
The combination or our unique Tranz-vector system and whole genome RNAi &
cDNA content enables our customers to perform drug target validation on a
large scale.
With our genomics resources, Open Biosystems provides
the content investigators utilize to unlock the functions of human genes and
their relationships to normal & disease development. We offer the most
complete gene library in the industry. This novel library consists of
several full length cDNA and open reading frame collections. Most
prominently among these is the Mammalian Gene Collection (MGC), the
industry’s gold standard gene catalog.
The discovery of RNA
interference has revolutionized the way investigators approach the studies
of gene expression, regulation and interactions, particularly as it relates
to drug development. Our collaboration with Drs. Greg Hannon (CSHL)
and Steve Elledge (Harvard) has led the way in the evolution of the short
hairpin RNA (shRNA) technologies to provide the life science community with
whole genome resources for human, mouse and rat with a multitude of
technology and delivery advantages.
To view our other products let us
invite you to visit our other websites like :
Gentaur /
Clonagen /
Genoprice / Bioxys /
Labprice
|